Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord-stromal tumors and provide clues to the histogenesis of hypercalcemic small cell carcinomas

International Journal of Gynecological Pathology

Volumn 17, Issue 1, 1998, Pages 46-53

  Riopel, Maureen A ^a   Perlman, Elizabeth J ^a   Seidman, Jeffrey D ^b   Kurman, Robert J ^a   Sherman, Mark E ^a,c  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c Pathology 430 ^*  (United States)

Author keywords

Granulosa cell tumor; Hypercalcemia; Immunohistochemistry; Inhibin; Leydig cell tumor; MIC2 gene; Ovary; Sertoli; Small cell carcinoma

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; INHIBIN;

ARTICLE; DYSGERMINOMA; FEMALE; GENE EXPRESSION; GRANULOSA CELL TUMOR; HISTOGENESIS; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; LEYDIG CELL TUMOR; MAJOR CLINICAL STUDY; OVARY TUMOR; PRIORITY JOURNAL; SERTOLI CELL TUMOR; SEX CORD TUMOR; STROMA CELL; TUMOR DIAGNOSIS;

EID: 0031963710     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199801000-00009     Document Type: Article

References (28)

1. Costa MJ, DeRose PB, Roth LM, Brescia RJ, Zaloudek CJ, Cohen C. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value. Hum Pathol 1994;25:60-6.
2. Miettinen M, Wahlstrom T, Virtsnen I, Talerman A, Astengo-Osuna C. Cellular differentiation in ovarian sex-cord-stromal and germ cell tumors studied with respect to intermediate-filament proteins. Am J Surg Pathol 1985;9:640-51.
3. Aguirre P, Thor A, Scully RE. Ovarian endometrioid carcinomas resembling sex cord stromal tumors. An immunohistochemical study. Int J Gynecol Pathol 1989;8:364-73.
4. Aguirre P, Thor A, Scully RE. Ovarian small cell carcinoma. Histogenic considerations based on immunohistochemical and other findings. Am J Clin Pathol 1989;92:140-9.
5. Ambros TM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 1991;67: 1886-93.
6. Fellinger EJ, Garin-Chesa P, Triche TJ, Huvos AG, Rettig WJ. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p 30/32 MIC2. Am J Pathol 1991;139:317-25.
7. Yamato M, Minami S, Nakano R. Immunohistochemical localization of inhibin subunits in polycystic ovary. J Clin Endocrinol Metab 1993;77:859-62.
8. Gurusinghe CJ, Healy DL, Jobling T, Mamers P, Burger HG. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol 1995;57:27-32.
9. Jobling T, Mamers P, Healy D, et al. A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol 1994;55: 185-9.
10. Riopel MA, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Huin Pathol 1994;25:396-9.
11. Goodfellow PJ, Darling SM, Thomas NS, Goodfellow PNA. Pseudoautosomal gene in man. Science 1986;234:740-3.
12. Perlman EJ, Dickman PS, Askin FB, Grier HE, Miser JS, Link MP. Ewing's sarcoma-routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group Children's Cancer Group intergroup study. Hum Pathol 1994;25:304-7.
13. Golin C, Aubrit F, Phalipon A, et al. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J 1989;8:3253-9.
14. Gordon M, Cortess C, Renshaw A, Beckstead J. CD99, keratin and vimentin staining of sex cord stromal tumors and normal ovary and testis. Mod Pathol 1996;520:90A.
15. Rishi M, Howard LN, Branhauer GL, Tavassoli FA. Utility of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 1997;21: 583-9.
16. Levy R, Dilley J, Fox RJ, Warnke R. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci USA 1979;76:6552-6.
17. Otis CN, Powell JL, Barbuto D, Carcangiu M. Intermediate filamentous proteins in adult granulosa cell tumors. Am J Surg Pathol 1992;16:962-8.
18. Flemming P, Wellman A, Maschek H, Lang H, Georgi A. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. Am J Surg Pathol 1995;19:927-33.
19. Zheng W, Sung CJ, Hanna I, et al. α and β subunits of inhibin/ activin as sex cord-stromal differentiation markers. Int J Gynecol Pathol 1997;16:263-71.
20. Amca PF, Roth LM, Walls J. Inhibin immunohistochemistry applied to ovarian neoplasms: a novel effective diagnostic tool. Mod Pathol 1997;555:96A.
21. Zheng W, Welt C, Lambert-Messerlian G, Sung CJ, Schmeyer AL, Felix JC. Asymmetric expression of inhibin and activin in ovarian epithelial carcinomas. Mod Pathol 1997;652:112A.
22. Hussong J, Woodruff T, Keh PC. Immunohistochemical study of primary ovarian tumors with inhibin antibody. Mod Pathol 1997; 589:102A.
23. Chadha S, van der Kwast T. Immunohistochemistry of ovarian granulosa cell tumors. Virchows Arch 1989;414:439-15.
24. Miettinen M, Lehto VP, Virtanen I. Expression of intermediate filaments in normal ovaries and ovarian epithelial, sex cordstromal, and germinal tumors. Int J Gynecol Pathol 1983;2:64-71.
25. Gitsch G, Kohlberger P, Steiner A, Neumeister B, Breitenecker G. Expression of cytokeratins in granulosa cell tumors and ovarian carcinomas. Arch Gynecol Obstet 1992;251:193-7.
26. Gitsch G, Kohlberger P, Hanzal E, Kolbl H, Breitenecker G. Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas. Arch Gynecol Obstet 1991;249: 173-7.
27. Scully RE. Small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol 1993;12:148-52.
28. Young RH, Oliva E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type: a clinical pathologic analysis of 150 cases. Am J Surg Pathol 1994;18:1102-16.